Imagene

Imagene AI Provides AI-Based Molecular Cancer Testing, Using Patients' Histological Data for Personalized Treatment. Imagene's AI diagnostic technology offers real-time molecular analysis using only digital biopsy images, setting a new standard by improving accuracy and reducing the time required for results from weeks to just two minutes. Imagene is also advancing a new method for predicting treatment response that encompasses each patient’s uniqueness, bringing cancer care closer to realizing the full potential of precision medicine.